Bulletin
Investor Alert

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 27, 2022, 7:59 p.m.

/zigman2/quotes/205619834/composite

$

146.90

Change

-0.76 -0.51%

Volume

Volume 123,115

Quotes are delayed by 20 min

/zigman2/quotes/205619834/composite

Previous close

$ 135.80

$ 147.66

Change

+11.86 +8.73%

Day low

Day high

$136.59

$148.54

Open

52 week low

52 week high

$119.01

$497.49

Open

Paul L. Sagan

Founder of Time Warner Cable Internet LLC (Virginia) and Pathfinder, Paul L. Sagan is a businessperson who has been at the helm of 7 different companies and occupies the position of Vice Chairman & President at Catalyst Partners Acquisition Corp., Principal at General Catalyst LLC and Non-Executive Chairman at L2, Inc. Mr. Sagan is also Chairman at ProPublica, Inc. and Member of Harvard University and on the board of 8 other companies.

He previously held the position of Chairman for Massachusetts Board of Elementary & Secondary Education, Director at Akamai Technologies, Inc., Advisory Board Member at Shelter Capital Partners LLC, Member of The Knight Commission On The Information Needs of Communities, Non-Executive Chairman of Datto, Inc., President & Editor-New Media at TI Gotham, Inc., Managing Editor-News at Time Warner, Inc., Senior Vice President for Time Warner Cable, Inc., Managing Director at General Catalyst Partners LLC, News Director at WCBS-TV, Membr at National Security Telecommunications Advisory Committee and Senior Advisor at Forum Mondial de L'Economie.

He received an undergraduate degree from Medill School of Journalism.

Transactions

Date Shares Transaction Value
04/28/2022 703   Derivative/Non-derivative trans. at $0 per share. 0
10/13/2021 2,250   Disposition at $314.9 per share. 708,525
08/12/2021 50,000   Gift at $0 per share. 0
02/14/2020 52,631   Acquisition at $19 per share. 999,989
12/11/2018 367,776   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Stéphane Bancel
Chief Executive Officer & Director
Dr. Stephen Hoge
President
Mr. David W. Meline
Chief Financial Officer
Dr. Paul Burton
Chief Medical Officer
Mr. Juan Andres
Chief Technical Operations & Quality Officer
Dr. Melanie Ivarsson
Chief Development Officer
Dr. Jacqueline Miller
Senior VP-Infectious Disease Development
Mr. Patrick Norman Bergstedt
Senior Vice President-Commercial Vaccines
Mr. Raymond C. Jordan
Chief Corporate Affairs Officer
Mr. John Lepore
Senior Vice President-Government Engagement
Dr. José M. Vega
Chief Safety Officer
Ms. Kate Cronin
Chief Brand Officer
Mr. Jonathan Hoggatt
Director-Hematology
Mr. Michael Mullette
Managing Director-Canada
Mr. Marcello Damiani
Chief Digital & Operational Excellence Officer
Ms. Lavina A. Talukdar
Senior Vice President & Head-Investor Relations
Ms. Tracey Franklin
Chief Human Resources Officer
Dr. Shannon Thyme Klinger
Secretary & Chief Legal Officer
Dr. Charbel Haber
Senior Vice President-Regulatory Affairs
Dr. Paula Hammond
Scientific Advisory Board
Dr. Noubar B. Afeyan
Chairman
Dr. Francois Nader
Independent Non-Executive Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth E. Tallett
Independent Director
Dr. Elizabeth G. Nabel
Independent Director
Mr. Paul L. Sagan
Independent Non-Executive Director
Dr. Robert S. Langer
Independent Non-Executive Director
Mr. Stephen A. Berenson
Independent Non-Executive Director
Link to MarketWatch's Slice.